Skip to main content

Burden of illness and treatment patterns among patients with peripheral T-cell lymphoma in the US healthcare setting.

Publication ,  Journal Article
Petrilla, AA; Shah, A; Feliciano, J; Woolery, J; LeBlanc, TW
Published in: Curr Med Res Opin
July 2021

OBJECTIVE: Limited real-world information exists on the characteristics or treatment patterns of patients with peripheral T-cell lymphoma (PTCL). We reported demographics, treatments and direct healthcare resource utilization (HRU) in a large cohort of US patients newly diagnosed with PTCL. METHODS: Patients aged ≥18 years with a PTCL diagnosis between January 2011 and December 2016 were identified from the Inovalon MORE2 Registry. Continuous medical/pharmacy enrollment 6-months prior to and ≥1-month after the first PTCL diagnosis was required. The main focus of this study was on newly diagnosed patients receiving cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) versus other chemotherapy. RESULTS: A total 2971 patients with PTCL and chemotherapy information were included in the study; 1706 (57%) received CHOP and 1265 (43%) other chemotherapy. A majority of patients (51.7%) were female; mean (standard deviation) age at index was 61.0 (±16.0), Charlson score was 4.1 (±2.9), and follow-up time was 24.6 (±16.7) months. During the variable follow-up period, HRU was similar for the CHOP and other chemotherapy cohorts; 58.1% and 59.3% had ≥1 all-cause hospitalizations, respectively. The proportion of patients with ≥1 PTCL-related hospitalizations was higher in the CHOP than in the other chemotherapy cohort (40.3% vs. 9.7%, respectively) and mean length of stay was longer (4.6 vs. 3.7 days per patient per month, respectively). CONCLUSIONS: This retrospective analysis of patients with PTCL revealed high levels of comorbidity and HRU; novel interventions that improve patient outcomes and reduce the HRU burden of PTCL are needed.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Curr Med Res Opin

DOI

EISSN

1473-4877

Publication Date

July 2021

Volume

37

Issue

7

Start / End Page

1189 / 1197

Location

England

Related Subject Headings

  • Retrospective Studies
  • Male
  • Lymphoma, T-Cell, Peripheral
  • Humans
  • General & Internal Medicine
  • Female
  • Delivery of Health Care
  • Cost of Illness
  • Antineoplastic Combined Chemotherapy Protocols
  • Adult
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Petrilla, A. A., Shah, A., Feliciano, J., Woolery, J., & LeBlanc, T. W. (2021). Burden of illness and treatment patterns among patients with peripheral T-cell lymphoma in the US healthcare setting. Curr Med Res Opin, 37(7), 1189–1197. https://doi.org/10.1080/03007995.2021.1920380
Petrilla, Allison A., Anne Shah, Joseph Feliciano, Joseph Woolery, and Thomas W. LeBlanc. “Burden of illness and treatment patterns among patients with peripheral T-cell lymphoma in the US healthcare setting.Curr Med Res Opin 37, no. 7 (July 2021): 1189–97. https://doi.org/10.1080/03007995.2021.1920380.
Petrilla AA, Shah A, Feliciano J, Woolery J, LeBlanc TW. Burden of illness and treatment patterns among patients with peripheral T-cell lymphoma in the US healthcare setting. Curr Med Res Opin. 2021 Jul;37(7):1189–97.
Petrilla, Allison A., et al. “Burden of illness and treatment patterns among patients with peripheral T-cell lymphoma in the US healthcare setting.Curr Med Res Opin, vol. 37, no. 7, July 2021, pp. 1189–97. Pubmed, doi:10.1080/03007995.2021.1920380.
Petrilla AA, Shah A, Feliciano J, Woolery J, LeBlanc TW. Burden of illness and treatment patterns among patients with peripheral T-cell lymphoma in the US healthcare setting. Curr Med Res Opin. 2021 Jul;37(7):1189–1197.

Published In

Curr Med Res Opin

DOI

EISSN

1473-4877

Publication Date

July 2021

Volume

37

Issue

7

Start / End Page

1189 / 1197

Location

England

Related Subject Headings

  • Retrospective Studies
  • Male
  • Lymphoma, T-Cell, Peripheral
  • Humans
  • General & Internal Medicine
  • Female
  • Delivery of Health Care
  • Cost of Illness
  • Antineoplastic Combined Chemotherapy Protocols
  • Adult